About us

We primarily focus our activities on a class of cellular biomarkers called integrins, in order to establish innovative clinical schemes for enhancing lifetimes and the quality of lives of patients with the most dreadful forms of this disease.

Follow us on our mission to exploit the most powerful and recent advances in bio- and radionuclide technology for the advancement of cancer diagnosis and therapy.

more about us link